| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| PG_35292 | 352.39 KB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
O vírus Ébola é um agente patogénico causador de uma doença sistémica, grave e com
alta taxa de mortalidade em humanos e primatas não-humanos. Foi descoberto pela
primeira vez em 1976 na República Democrática do Congo. Existem cinco espécies
conhecidas do vírus, das quais quatro foram identificadas na África Equatorial. Uma vez
que entra na população humana a transmissão ocorre principalmente pelo contato com
fluídos corporais contaminados. O vírus causa uma supressão do sistema imunitário, bem
como uma resposta inflamatória acentuada e grande perda de fluídos e eletrólitos. Embora
existam vacinas e tratamentos em desenvolvimento, a gestão dos casos baseia-se na
sintomatologia e manutenção e reposição de fluídos e eletrólitos, para prevenção e
controlo da falência de órgãos. Em 2014 a Organização Mundial da Saúde classificou a
epidemia causada pelo vírus Ébola como um problema da saúde pública em África e que
preocupa o mundo. O Centro de Controlo e Prevenção de Doenças dos Estados Unidos
listou o vírus Ébola como um agente de bioterrorismo de categoria A.
The Ebola virus is a pathogen causing a systemic, severe disease with a high mortality rate in humans and non-human primates. It was first discovered in 1976 in the Democratic Republic of congo. There are five known species of the virus, four of which have been identified in Equatorial Africa. Once it enters the human population transmission occurs mainly by contact with infected body fluids. The virus causes a suppression of the immune system, as well as a marked inflammatory response and large loss of fluids and electrolytes. Although vaccines and treatments are in development, case management is based on symptomatology and maintenance and replacement of fluids and electrolytes, for prevention and control of organ failure. In 2014, the World Health Organization classified the Ebola virus epidemic as a public health problem in Africa that worries the world. The U.S. Centers for Disease Control and Prevention has listed the Ebola virus as a Category A bioterrorism agent.
The Ebola virus is a pathogen causing a systemic, severe disease with a high mortality rate in humans and non-human primates. It was first discovered in 1976 in the Democratic Republic of congo. There are five known species of the virus, four of which have been identified in Equatorial Africa. Once it enters the human population transmission occurs mainly by contact with infected body fluids. The virus causes a suppression of the immune system, as well as a marked inflammatory response and large loss of fluids and electrolytes. Although vaccines and treatments are in development, case management is based on symptomatology and maintenance and replacement of fluids and electrolytes, for prevention and control of organ failure. In 2014, the World Health Organization classified the Ebola virus epidemic as a public health problem in Africa that worries the world. The U.S. Centers for Disease Control and Prevention has listed the Ebola virus as a Category A bioterrorism agent.
Description
Projeto de Graduação apresentado à Universidade Fernando Pessoa para obtenção do grau de Licenciada em Enfermagem
Keywords
Ebola vírus Ebola virus disease Nursing
